Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Deal in September ?

<< Previous

Bullboard Posts

Next >>

Comment by Charly50on Sep 09, 2021 4:36am

218 Views

Post# 33829874

RE:RE:Deal in September ?

Dear Philip,

thank you very much for your quick reply. You have helped me a lot with that.

Assuming your consent, I will continue to trasnport your answers. Is that okay for you?

One last question:
How many collaborations are you aiming for this year (3,5,7....)

I wish you and your team success in your negotiations.

With kind regards from Germany and great confidence in your highly appreciated work.

Charly

Hi Charlie,

I am in different stages of discussions with a minimum of 6 companies.

Best regards,

Philip

Dear Charly,

Also the fact that Dr. P. Witkowski is still looking for a 7th patient makes me think.
Why is the search proving so difficult?

Our enrolment criteria for patients is very strict for this study. In order to prove that when we find insulin in the bloodstream it is coming from the islets in the Cell Pouch the patients must show that they are unable to produce any insulin on their own. This has made for a much stronger clinical study. In fact we have had a number of candidates apply for the 7^th position but they have not passed all the tests to enter the study. We have additional candidates that we are assessing and will announce when we have the candidate enrolled. As we move forward with next studies we hope to expand enrolment criteria as we have now proven that the Cell Pouch with islets is working.

There is nothing to worry about.

How likely is a license deal in the month of September?

We are working with multiple pharmaceutical companies and medtech companies. We are working hard to get a deal as soon as possible. In negotiations I as CEO need to get the best deal for our investors and not just take any deal. Every license agreement I have negotiated has gotten Sernova excellent terms and I will continue to fight for the best deals for Sernova and our investors. Thus I am hoping we will achieve a deal in September as we are working daily on this.

Hope that helps….